Cheddar News checks in with a coast-to-coast forecast of the weather for Thursday, Aug. 3, 2023.
Share:
More In Science
5,000 Attend Rock Concert in Barcelona After COVID-19 Screen
Five thousand music lovers attended a rock concert in Barcelona after passing a same-day COVID-19 screening.
Biden, CDC Director Warn of Virus Rebound if Nation Lets Up
President Joe Biden and CDC Director Dr. Rochelle Walensky are making impassioned pleas to Americans not to let their guard down in the fight against COVID-19.
WHO Draft Report Says Animals Likely Source of COVID-19
A joint WHO-China study on the origins of COVID-19 says that transmission from bats to humans through another animal is the most likely scenario and that a lab leak of the coronavirus is “extremely unlikely.”
Biden Leaves Door Open for Senate Change to Pass Agenda
President Joe Biden is leaving the door open to backing fundamental changes in Senate procedure to muscle key parts of his agenda past Republican opposition.
Why You Shouldn't Post That Vaccine Card Selfie
Posting that photo of yourself next to your vaccination card on social media could potentially make you a target for people trying to steal your personal information.
Brighter Outlook for U.S. as Vaccinations Rise and Deaths Fall
More than three months into the U.S. vaccination drive, many of the numbers paint an increasingly encouraging picture.
NoseFrida Maker Expanded Line to Prepare Moms to Get Through Postpartum
Chelsea Hirschhorn, Frida CEO, talked to Cheddar about the company's new breast care products meant to help women navigate the postpartum period.
How Starbucks Sustainably Built a New Store Outside Vancouver in Just Six Days
Gregor Robertson, former mayor of Vancouver and executive vice president of strategy at Nexii Building Solutions spoke to Cheddar about raising a Starbucks location with a smaller carbon footprint while staying affordable and efficient.
U.S. Health Officials: AstraZeneca Results May Have Included Outdated Info
American federal health officials say results from a U.S. trial of AstraZeneca’s COVID-19 vaccine may have included “outdated information” and that could mean the company provided an incomplete view of efficacy data.
